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Background: The Ay allele at the agouti locus causes obesity and promotes linear growth in mice. The effect of the
Ay allele on obesity has been extensively investigated, whereas its effect on body length is only poorly analyzed. To
gain insight into the genetic control of body length, quantitative trait locus (QTL) analysis was performed in F2
female mice produced by crossing C57BL/6 J females and DDD.Cg-Ay males. A congenic DDD.Cg-Ay strain was
established by introgressing the Ay allele from the B6.Cg-Ay strain by backcrossing for 12 generations. DDD.Cg-Ay
females were longer than B6.Cg-Ay females; therefore, QTLs that interact with the Ay allele may be identified for
body length. In addition, QTL analysis was also performed for plasma insulin-like growth factor 1 (IGF1) levels
because IGF1 is known to play essential roles in growth and development. If QTLs for IGF1 levels coincide with
those for body length, we can gain endocrinological insight into the QTLs for body length.
Results: Correlations between body length and IGF1 levels were statistically significant in F2 populations. For body
length, two significant QTLs were identified on chromosomes 15 and 17. For IGF1 levels, three significant QTLs
were identified on chromosomes 10, 12, and 19. QTLs on chromosomes 12 and 19 appeared to be novel, and the
latter interacted with the Ay allele.
Conclusion: QTLs for body length and IGF1 levels contained candidate genes that were components of the
growth hormone/insulin-like growth factor axis. However, there was no overlap between QTLs for these two traits.
Contrary to our expectations, QTLs that interacted with the Ay allele were identified not for body length but for
IGF1 levels. Body length and IGF1 levels were, thus, controlled by different sets of genes.
Keywords: Ay allele, Body length, Plasma IGF1 levels, Quantitative trait locus (QTL)Background
Traditionally, five single gene obesity mutations, Cpefat,
Tubtub, Lepob, Leprdb, and Ay, have been identified in
mice [1]. Among the five mutations, only the Ay allele is
dominant and homozygous lethal; therefore, living Ay
mice are invariably heterozygotes. Obesity in Ay mice is
moderate and occurs late compared with that in the
other four mutants. The Ay allele is known not only to
cause obesity but also to promote linear growth [2].
In normal mice, the agouti gene is expressed only in
the skin [3,4], and it regulates pigmentation by serving
as an inverse agonist of the melanocortin 1 receptorCorrespondence: jsuto@affrc.go.jp
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reproduction in any medium, provided the or[5,6]. However, in Ay mice, the Ay allele is associated
with a large deletion, causing agouti gene expression to
be aberrantly controlled by the unrelated Raly gene pro-
moter and leading to its ectopic overexpression [4,7-9].
As a result, Ay mice have a yellow coat color and develop
maturity onset obesity. Obesity in Ay mice is believed to
be a consequence of the agouti protein serving as a con-
stitutive antagonist of the melanocortin 3 receptor
(MC3R) and melanocortin 4 receptor (MC4R) by mim-
icking the action of the agouti-related protein [10-12].
Two mouse strains congenic for the Ay allele are avail-
able to date: B6.Cg-Ay (C57BL/6 J background, hereafter
B6-Ay) and KK.Cg-Ay (KK/Ta background, hereafter KK-Ay)
strains. We developed a novel strain congenic for the Ay
allele in an inbred DDD/Sgn (hereafter DDD) strain back-
ground, i.e., DDD.Cg-Ay (hereafter DDD-Ay) strain [13].s is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Mean± S.E. body length and plasma IGF1 levels
in parental, F1, and F2 female mice
Mice n Body length (mm) IGF1 (ng/ml)
DDD-Ay 8 102.39 ± 0.43 c, d 679.3 ± 18.9 d, h
DDD 9 98.22 ± 0.37 e 603.7 ± 18.8 e
B6-Ay 5 96.79 ± 0.71 e 465.2 ± 27.8 i
B6 7 90.53 ± 0.55 346.6 ± 12.7
F1 non-A
y 7 nd f 426.9 ± 21.2
F1 A
y 7 nd f 443.4 ± 14.3
F2 non-A
y 148 (137) a 95.42 ± 0.27 g 459.5 ± 5.8
F2 A
y 150 (139) b 99.73 ± 0.22 445.6 ± 5.8
a The number of F2 mice is 148 for plasma IGF1 levels and 137 for
body length.
b The number of F2 mice is 150 for plasma IGF1 levels and 139 for
body length.
c Significant difference (P < 0.0001) versus DDD.
d Significant difference (P < 0.0001) versus B6-Ay.
e Significant difference (P < 0.0001) versus B6.
f nd, not determined.
g Significant difference (P < 0.0001) versus F2 A
y.
h Significant difference (P < 0.05) versus DDD.
i Significant difference (P < 0.01) versus B6.
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ity compared with KK-Ay and B6-Ay females [14], i.e., the
average body weight at 16 weeks was 54.2 g in DDD-Ay,
52.2 g in KK-Ay, and 38.5 g in B6-Ay. Although KK-Ay and
B6-Ay females did not weigh more than 60 g (body
weights were measured by 29 weeks), DDD-Ay females
weighed more than 60 g at 19 weeks and older and some
weighed more than 70 g by 22 weeks. The magnitude of
phenotypic effect of the Ay allele was thus strongly influ-
enced by the genetic background.
To determine the genetic basis of obesity in DDD-Ay
mice and to determine whether or not their high body
weight was because of the presence of DDD
background-specific modifiers, quantitative trait locus
(QTL) analyses for body weight and obesity (defined by
body mass index, BMI) were previously performed in
two types of F2 female mice [F2 A
y (F2 mice with the A
y
allele) and F2 non- A
y mice (F2 mice without the A
y al-
lele)] produced by crossing C57BL/6 J females and
DDD-Ay males [14]. The presence of DDD background-
specific modifiers was not confirmed, and a multifactor-
ial basis for obesity in DDD-Ay females was revealed.
In this study, the genetic basis of body length was ana-
lyzed in the same F2 population. In addition to the
results of the analysis of body weight, we will gain
insight into the genetic control of body size because
body length also serves as a representative body size par-
ameter. Furthermore, the Ay allele is known not only to
cause obesity but also to promote linear growth [2]. The
effect of the Ay allele on body weight has been exten-
sively investigated, whereas its effect on body length is
only poorly analyzed [15,16]. As with obesity, the effect
of the Ay allele on body length was considered to be
mediated by the melanocortin 4 receptor [11]. DDD.Cg-
Ay strain was longer than B6.Cg-Ay strain; therefore,
DDD background-specific modifiers may be identified
for body length.
In addition, QTL analysis was also performed for
plasma insulin-like growth factor 1 (IGF1) levels because
QTLs identified for body length contained candidate
genes that were components of the growth hormone/
insulin-like growth factor axis and because IGF1 is
known to play essential roles in growth and develop-
ment [17-21]. Thus, we hypothesized that some QTLs
for IGF1 levels will be involved in the control of body
length. If QTLs for IGF1 levels coincide with those for
body length, we can gain endocrinological insight into
the QTLs for body length.
Results
Body length and plasma IGF1 levels in parental, F1, and
F2 female mice are summarized in Table 1. In parental
female mice, Ay mice were significantly longer and had
significantly higher IGF1 levels than non-Ay mice.Furthermore, DDD-Ay females were significantly longer
and had significantly higher IGF1 levels than B6-Ay
females and DDD females were significantly longer and
had significantly higher IGF1 levels than B6 females. In
F2 females, A
y mice were significantly longer than non-
Ay mice, but IGF1 levels did not significantly differ be-
tween Ay and non-Ay mice.
Histograms showing the distribution of body length in F2
females are shown in Figure 1 [(A) F2 non-A
y females,
n= 137, (B) F2 A
y females, n= 139]. Mean±S.E. body length
was significantly larger in F2 A
y females (99.73±0.22 mm)
than F2 non-A
y females (95.42±0.27 mm) (P<5.2× 10–28).
In combined F2 females (F2 non-A
y plus F2 A
y), body length
was normally distributed. Histograms showing the distribu-
tion of IGF1 levels in F2 females are shown in Figure 2 [(A)
F2 non-A
y, n = 148, (B) F2 A
y females, n= 150]. Mean±S.E.
IGF1 levels did not significantly differ between F2 non-A
y
(459.5± 5.8 ng/dl) and F2 A
y (445.6± 5.8 ng/dl) (P >0.09)
females. In combined F2 females, IGF1 levels were not
normally distributed; therefore, IGF1 levels were nor-
malized by Box-Cox transformation. Compared to a
relatively high correlation between body length and
body weight, correlations between body weight and
IGF1 levels and between body length and IGF1 levels
were modest albeit all correlations were statistically
significant in both the F2 non-A
y and F2 A
y females
(Table 2).
Because the Ay allele had a large phenotypic effect on
IGF1 levels, the agouti locus genotype (non-Ay or Ay)
was included as an additive covariate in the following
QTL mapping analyses. For body length, two significant
QTLs were identified on chromosomes 15 and 17, and
two suggestive QTLs were identified on chromosomes 6
Figure 1 Histograms showing the distributions of body length
(mm) in F2 non-A
y (A) and F2 A
y (B) mice.
Figure 2 Histograms showing the distributions of plasma IGF1
levels (ng/ml) in F2 non-A
y (A) and F2 A
y (B) mice.
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symbols Blndq1 (body length in DDD QTL no. 1) and
Blndq2 to the significant QTLs. The DDD allele was
associated with increased body length at the Blndq1
(Figure 4A), whereas the DDD allele was associated with
decreased body length at the blndq2 (Figure 4B). There
were no significant pair-wise interactions.
Because the difference between the LOD score with
the agouti locus genotype as an interactive covariate and
the LOD score with the agouti locus genotype as an
additive covariate concerns the test of the QTL× agoutilocus genotype interaction, this was performed. How-
ever, there were no significant QTLs that interacted with
the Ay allele.
For IGF1 levels, two significant QTLs were identified
on chromosomes 10 and 12, and four suggestive QTLs
were identified on chromosomes 8, 13, 14, and 19
(Table 3 and Figure 3). We assigned the gene symbols
Igfdq1 (IGF1 levels in DDD QTL no. 1) and Igfdq2 to
the significant QTLs. The DDD allele was associated
with increased IGF1 levels at the Igfdq1 (Figure 4C),
whereas the heterozygous genotype was associated with
increased IGF1 levels at the Igfdq2 (Figure 4D). There
were no significant pair-wise interactions.
Table 2 Pearson coefficient of correlation in F2 female mice
F2 non-A
y mice F2 A
y mice
Body length IGF1 levels Body length IGF1 levels
Body weight 0.7506 (P < 0.0001) 0.2004 (P < 0.02) Body weight 0.6413 (P < 0.0001) 0.2708 (P < 0.002)
Body length 0.2576 (P < 0.003) Body length 0.3077 (P < 0.0003)
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was tested, one significant interacting QTL was identi-
fied on chromosome 19 (Table 4 and Figure 5). We
assigned the gene symbol Igfdq3 to this locus. Indeed, a
direction of allele effect of this QTL differed between F2
non-Ay and F2 A
y females (Figure 4E). Thus, Igfdq3
interacted with the Ay allele.
Discussion
Blndq1 (chromosome 15) and Blndq2 (chromosome 17)
are major determinants of body length. These QTLs did
not interact with the Ay allele, and the allele effect of
these QTLs was in the same direction in F2 non-A
y and
F2 A
y mice. When the agouti locus genotype was
included as a covariate in the analysis, no significant
QTL× covariate interactions were identified. When the
same analysis was applied to the body weight data,
which was previously analyzed, no significant QTL×
covariate interactions were identified. Thus, although
DDD-Ay females were heavier and longer than B6-Ay
mice, we could not identify any QTLs that interacted
with the Ay allele. The effect of the Ay allele on size is
probably rather complex in its physiologic mechanism of
action. Indeed, we previously observed that the Ay allele
decreased the size of the mandibular bone and the testis
weight significantly [13,22].
In agreement with the results by Reed et al. [23], in
which the correlation coefficient between body weightTable 3 QTLs identified by single QTL scans with the agouti lo
Trait Chromosome Location (cM) a 95% CI (cM) b










a Location indicates a map position showing a peak LOD score in cM.
b 95% CI is defined by a 1.5-LOD support interval.
c Maximum LOD score for QTL. Significant QTLs are indicated by * (suggestive QTLs
d Allele associated with higher trait values. Het, heterozygous genotype is associate
with the agouti.
e Assignment of QTL name is limited to significant QTLs.and body length in a mouse F2 intercross was 0.67, the
correlation coefficient between weight and body length
was similarly high in F2 non-A
y and F2 A
y mice in this
study. Blndq2 colocalized with Bwdq3, which was identi-
fied for body weight in a previous study using the same
F2 intercross [14]. At both the QTLs, the DDD allele
was associated with decreased trait values, which sug-
gests that these QTLs may be allelic and play a role in
determining overall body size. Also, Blndq1 colocalized
with a suggestive QTL for body weight. A suggestive
QTL for body length identified on chromosome 6 over-
lapped with a significant QTL for body weight, Bwdq2.
Thus, there were some overlaps between QTLs for body
length and body weight.
Although there are only a limited number of studies
on body length as compared with studies on body
weight, body length QTLs have been reported by others.
Among the results of such studies, QTLs for body length
have been mapped to chromosome 2 several times. Reed
et al. [23] identified significant QTLs on chromosome 2
(Bdln3), near the agouti locus, in an F2 intercross be-
tween 129P3/J and C57BL/6ByJ. Farber and Medrano
[24] identified a significant QTL (Bdlnq7) on distal
chromosome 2 in an F2 intercross between the CAST/
EiJ and B6-hg/hg strains. Chiu et al. [25] presented evi-
dence that a significant QTL was present on distal
chromosome 2 using subcongenic strains for obesity.
Masinde et al. [19] identified Lgth1 and Lgth2 oncus as an additive covariate
Max LOD c Nearest marker High allele d Name e
2.58 D6Mit39 B6
2.58 D11Mit236 DDD
4.16 * D15Mit174 DDD Blndq1
3.94 * D17Mit176 B6 Blndq2
3.07 D8Mit191 B6
9.60 * D10Mit42 DDD Igfdq1




are presented without asterisk).
d with higher trait values. na, not applicable because this QTL interacts
Figure 3 LOD score plots for body length and IGF1 levels by single QTL scan with the agouti locus genotype as an additive covariate.
The x-axis shows the chromosome numbers and the y-axis shows the LOD scores at these locations. Blue lines indicate the LOD scores for body
length, and red lines indicate the LOD scores for IGF1 levels. Horizontal dashed lines (color-coded by each trait) indicate significant threshold LOD
scores determined by 1,000 permutations.
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MPJ and SJL/J strains. Apparently, the agouti locus is
one of the plausible candidate genes for these QTLs.
Body length QTLs were also reported for other chro-
mosomes. Reed et al. [23] identified Bdln6, which was
significant only for males, on chromosome 4 in the sameFigure 4 Allelic contributions to QTLs for body length on (A) chromo
(C) chromosomes 10, (D) 12, and (E) 19. Homozygous DDD alleles are re
heterozygous alleles by DDD/B6. The y-axes show the mean trait values anF2 intercross described previously. Masinde et al. [19,20]
identified Lgth3 on chromosome 4, Lgth4 and Lgth5 on
chromosome 9, Lgth6 on chromosome 11, Lgth7 and
Lgth8 on chromosome 13, and Lgth9 on chromosome 17
in the same F2 intercross described previously. The 95%
CI for Lgth6 overlapped with that for suggestive QTL onsomes 15 and (B) 17, and those to QTLs for IGF1 levels on
presented by DDD/DDD, homozygous B6 alleles by B6/B6, and
d the error bars show SE.
Table 4 Summary of single QTL scans for IGF1 levels in
F2 female mice using the agouti locus genotype
as a covariate













10 9.60 (36, Igfdq1) 11.11 (35, Igfdq1)
12 4.11 (54, Igfdq2) 4.88 (54, Igfdq2)
19 3.62 (61, Igfdq3)
Only significant QTLs are listed.
a Significant threshold LOD scores are 3.29 for autosomes and 2.74 for
X chromosome.
b Significant threshold LOD scores are 4.39 for autosomes and 3.49 for
X chromosome.
c LODi is the difference between the LOD score with agouti as an interactive
covariate (LODf) and the LOD score with agouti as an additive covariate
(LODa). It concerns the test of the QTL × agouti interaction. Significant
threshold LOD scores are 2.50 for autosomes and 3.06 for X chromosome.
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which suggests that these loci are allelic.
It is important to note that more than a few of these
QTLs for body length have candidate genes that were
contained in growth hormone/insulin-like growth factor
axis. Indeed, the 95% CI for Blndq1 on the proximal part
of chromosome 15 contains growth hormone receptor
(Ghr) locus and the 95% CI for Blndq2 on proximal
chromosome 17 contains insulin-like growth factor 2 re-
ceptor (Igf2r) as candidate genes. Therefore, we next
performed QTL analysis on IGF1 levels.
Surprisingly, there was no overlap between QTLs for
body length and IGF1 levels. This suggests that genetic
variations affecting IGF1 levels did not have substantial
effects on body length. Igfdq1 (chromosome 10) and
Igfdq2 (chromosome 12) are primary determinants of
IGF1 levels. Igfdq1 and Igfdq2 did not interact with theFigure 5 Interaction LOD score plots for the IGF1 levels. A horizontal d
1,000 permutations. Solid lines denote the LOD scores when the agouti ge
lines indicate significant threshold LOD scores determined by 1,000 permuAy allele, and the allele effect of these QTLs was in the
same direction in F2 non-A
y and F2 A
y mice. In contrast,
Igfdq3 interacted with the Ay allele. The 95% CI for
Igfdq3 contains Kazal-type serine peptidase inhibitor do-
main 1 (Kazald1), which is also known as Igfbp-rp10, as
a candidate gene. Kazald1 is shown to promote prolif-
eration of osteoblasts during bone formation and bone
regeneration [26].
To date, four other studies have addressed blood
(plasma or serum) IGF1 levels in mouse intercrosses
[27-30]. Brockmann et al. [27] identified two significant
QTLs on chromosomes 10 and 18 in an F2 intercross
between Du6i and DBA/2 mice. They reported that
chromosomal regions harboring these QTLs did not
show any linkage to body, muscle, or fat weight. Rosen
et al. [28] identified three significant QTLs on chromo-
somes 6, 10, and 15 in an F2 intercross between C3H/
HeJ and B6. Harper et al. [29] identified five significant
QTLs on chromosomes 1, 3, 8, 10, and 17 in genetically
heterogeneous mice. Leduc et al. [30] identified four sig-
nificant QTLs on chromosomes 9, 10, 15, and 17 in F2
mice between MRL/MpJ and SM/J. Thus, Igfdq2
(chromosome 12) and Igfdq3 (chromosome 19), identi-
fied in this study, are considered to be novel QTLs for
blood IGF1 levels. In particular, Igfdq3 was shown to
interact with the Ay allele. Most importantly, all five
studies, including the present study, identified a signifi-
cant QTL on chromosome 10 at a position containing
the Igf1 locus, and it was considered that the Igf1 itself
was a plausible candidate gene for the QTL. To deter-
mine whether or not Igf1 is responsible for Igfdq2, fur-
ther studies, including sequence and expression
analyses, will be required [28,30,31].
Finally, we could not analyze the distal portion of
chromosome 2 (surrounding the agouti locus) and the
mid-part of chromosome 7 (surrounding tyrosinaseashed line indicates significant threshold LOD scores determined by
notypes (non-Ay or Ay) were included as covariates. Horizontal dashed
tations.
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http://www.biomedcentral.com/1756-0500/5/547locus) because these chromosomal regions in DDD-Ay
strain were derived from B6-Ay strain. In particular, the
allele at the distal chromosome 2 was biased toward the
B6 allele in F2 non-A
y mice, whereas the allele was
biased toward the DDD allele in F2 A
y mice. Also, we
could not sufficiently analyze the entire part of X
chromosome due to the cross direction of parental
strains. Therefore, we cannot deny a possibility that
there are additional QTLs in these chromosomal
regions. Most importantly, because the present study
was conducted in females, the QTL effect may not ne-
cessarily be confirmed in males. We are currently estab-
lishing QTL congenic strains to confirm the presence
and effect of the QTLs in both sexes.Conclusion
In summary, QTLs for body length and IGF1 levels con-
tained candidate genes that were components of the
growth hormone/insulin-like growth factor axis. How-
ever, there was no overlap between QTLs for each trait.
Contrary to our expectations, a QTL that interacted with
the Ay allele was identified not for body length but for
IGF1 levels. Body length and IGF1 levels were thus con-
trolled by different sets of genes.Methods
Mice
The inbred mouse DDD strain (agouti locus genotype,
A/A) and the congenic mouse DDD-Ay strain (Ay/A)
were maintained at the National Institute of Agrobio-
logical Sciences (NIAS). The inbred mouse C57BL/6 J
strain (hereafter designated B6, a/a) was purchased from
Clea Japan (Clea Japan Inc., Tokyo). The congenic
mouse B6-Ay strain (Ay/a) was purchased from The Jack-
son Laboratory (Bar Harbor, ME, USA). The DDD-Ay
strain was established by introgressing the Ay allele from
the B6-Ay strain in the DDD strain by backcrossing for
12 generations [13]. Hereafter, both DDD-Ay and B6-Ay
are referred to as “Ay mice.” Similarly, their control lit-
termates, DDD and B6, are referred to as “non-Ay mice.”
DDD-Ay males were crossed with B6 females to pro-
duce the F1 generation, and F1 A
y (Ay/a) mice were
intercrossed with F1 non-A
y (A/a) mice to produce the
F2 generation. F2 females were weaned at 4 weeks. The
mice were housed in groups of 4–5 for 16 weeks.
All mice were maintained in a specific pathogen-free
facility with a regular light–dark cycle (12 h light and
12 h dark) and controlled temperature (23 ± 1°C) and
humidity (50%). Food (CRF-1; Oriental Yeast Co Ltd.,
Tokyo, Japan) and water were freely available throughout
the experimental period. All animal experiments were
performed in accordance with the guidelines of the Insti-
tutional Animal Care and Use Committee of NIAS.Phenotyping
At the age of 16 weeks, the body weight of the mice,
fasted for 4 h, was determined using an electric balance
to the nearest 0.01 g. The mice were euthanized with an
overdose of ether. Whole blood was drawn from the
heart into a plastic tube using heparin as an anticoagu-
lant. Sample tubes were centrifuged at 7,000 rpm for
5 min at −4°C to separate the plasma. The plasma sam-
ples were maintained at −80°C until use. The IGF1 con-
centration was determined by ELISA (R&D Systems,
Inc., Minneapolis, MN55413, USA). The anal–nasal
length of each mouse was measured by a pair of digital
calipers to the nearest 0.01 mm just after the blood col-
lection to avoid rigor mortis. Body length is defined as
the anal–nasal length in this study.
Normality of the distribution of trait data for com-
bined F2 females (F2 non-A
y plus F2 A
y, n = 298) was
tested using the Shapiro–Wilk W test (JMP 8.0.2, SAS
Institute Japan, Tokyo, Japan). If the trait values did not
follow a normal distribution, they were appropriately
normalized using the Box–Cox transformation.
Genotyping and QTL analysis
Genomic DNA isolation and genotyping of microsatellite
markers were performed according to the procedure
described in our previous study [14]. Microsatellite mar-
kers used in this study were listed in the Table 5 with their
map position (cM) calculated using combined F2 females.
It should be noted that chromosome 7 is divided into
two parts. Due to the introgression of the Tyr locus from
the B6 strain, a mid-part of the DDD genome on
chromosome 7 is replaced by a B6 genome in DDD-Ay
mice. In this study, a region proximal to the B6 region
was defined as “chromosome 7.1 (D7Mit250).” whereas a
region distal to the B6 region was defined as “chromo-
some 7.2 (D7Mit362).”
Of a total of 298 F2 females, 148 were F2 non-A
y and
150 were F2 A
y mice. QTL analysis was performed using
R/qtl [33,34]. Data for F2 non-A
y and F2 A
y mice were
combined and analyzed using the agouti locus genotype
(i.e., Ay or non-Ay) as a covariate. Threshold logarithm
of odds (LOD) scores for suggestive (P < 0.63) and sig-
nificant (P < 0.05) linkages were determined by perform-
ing 1,000 permutations for each trait [35]. For significant
QTLs, a 95% confidence interval (CI) was defined by a
decline of 1.5 LOD. After these single QTL scans, pair-
wise evaluations for potential interactions between loci
were made. At this stage, threshold LOD scores were
based strictly on those recommended by Broman in “A
Brief Tour of R/qtl” (http://www.rqtl.org).
Other statistics
Statistical analysis for the two groups was performed
using Student’s or Welch’s t-test, while that for more
Table 5 Genetic markers and their map positions used in this study
Marker a Map position b Marker Map position Marker Map position Marker Map position
Chromosome 1 Chromosome 6 Chromosome 11 Chromosome 16
D1Mit231 0 D6Mit116 0 D11Mit236 0 D16Mit131 0
D1Mit303 31.6 D6Mit224 12.2 D11Mit36 34.6 D16Mit57 21.8
D1Mit10 46.1 D6Mit188 22.6 D11Mit124 44.8 D16Mit136 36.1
D1Mit102 67.2 D6Mit39 41.7 D11Mit61 62.6 D16Mit139 44.3
D1Mit16 77.7 D6Mit108 44.0 D16Mit49 53.0
Apoa2 80.2 D6Mit256 55.7 Chromosome 12
D1Mit291 86.1 D6Mit259 67.2 D12Mit136 0 Chromosome 17
D12Mit172 6.6 D17Mit164 0
Chromosome 2 Chromosome 7.1 D12Mit156 23.4 D17Mit176 25.1
D2Mit312 0 D7Mit250 0 D12Mit259 32.7 D17Mit139 33.9
D2Mit296 38.9 D12Mit141 49.3 D17Mit93 47.5
D2Mit92 60.7 Chromosome 7.2 D12Nds2 53.6 D17Mit123 69.5
D7Mit362 0
Chromosome 3 Chromosome 13 Chromosome 18
D3Mit203 0 Chromosome 8 D13Mit207 0 D18Mit21 0
D3Mit25 18.5 D8Mit191 0 D13Mit64 18.8 D18Mit149 15.7
D3Mit212 30.3 D8Mit205 3.6 D13Mit110 56.5 D18Mit152 23.9
D8Mit249 14.5 D13Mit213 66.2 D18Mit25 54.8
Chromosome 4 D8Mit183 23.2 D13Mit171 71.3
D4Mit1 0 Chromosome 19
D4Mit178 26.0 Chromosome 9 Chromosome 14 D19Mit32 0
D4Mit166 37.3 D9Mit59 0 D14Mit64 0 D19Mit91 59.0
D4Mit234 82.3 D9Mit191 14.9 D14Mit193 13.3 D19Mit35 65.0
D9Mit207 25.4 D14Mit165 30.7
Chromosome 5 D9Mit198 38.2 Chromosome X
D5Mit267 0 D9Mit212 51.3 Chromosome 15 DXMit166 0
D5Mit113 21.6 D15Mit174 0 DXMit119 11.2
D5Mit239 30.2 Chromosome 10 D15Mit184 26.3 DXMit64 27.2
D5Mit161 43.0 D10Mit188 0 D15Mit193 82.2 DXMit38 36.7
D5Mit221 61.6 D10Mit183 5.6
D10Mit42 59.1
D10Mit95 66.3
a Apoa2 (apolipoprotein A-II) was genotyped with a PCR-RFLP method according to the Suto et al. [32] procedure.
b Map positions (cM) were based on a linkage map calculated using combined F2 females (n = 298).
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http://www.biomedcentral.com/1756-0500/5/547than two groups was performed using Tukey-Kramer
HSD test (JMP 8, SAS Institute Inc., Cary, NC 27513,
USA). Strength of association between body weight and
body length was evaluated by using the Pearson product
moment correlation coefficient. P < 0.05 was considered
to be statistically significant.
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